MTOR and the health benefits of exercise

Seminars in Cell and Developmental Biology

Volumn 36, Issue , 2014, Pages 130-139

  Watson, Kurt ^a   Baar, Keith ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amino acids; Cancer; Inactivity; Longevity; Quality of life

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOCHONDRIAL PROTEIN; MUSCLE PROTEIN;

BRAIN; ENDURANCE TRAINING; EXERCISE; HEART; HUMAN; METABOLIC STRESS; MUSCLE EXERCISE; MUSCLE GROWTH; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; SKELETAL MUSCLE;

EID: 84912115519     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.08.013     Document Type: Review

References (126)

1. Blair S.N. Physical inactivity: the biggest public health problem of the 21st century. Br J Sports Med 2009, 43:1-2.
2. Ruiz J.R., Sui X., Lobelo F., Morrow J.R., Jackson A.W., Sjostrom M., et al. Association between muscular strength and mortality in men: prospective cohort study. BMJ 2008, 337:a439.
3. Rantanen T., Masaki K., He Q., Ross G.W., Willcox B.J., White L. Midlife muscle strength and human longevity up to age 100 years: a 44-year prospective study among a decedent cohort. Age (Dordr) 2012, 34:563-570.
4. Belardinelli R., Georgiou D., Cianci G., Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 1999, 99:1173-1182.
5. Courneya K.S., Mackey J.R., Bell G.J., Jones L.W., Field C.J., Fairey A.S. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003, 21:1660-1668.
6. Courneya K.S. Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc 2003, 35:1846-1852.
7. Morris J.N., Kagan A., Pattison D.C., Gardner M.J. Incidence and prediction of ischaemic heart-disease in London busmen. Lancet 1966, 2:553-559.
8. Lindstrom J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemio K., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673-1679.
9. Raguso C.A., Kyle U., Kossovsky M.P., Roynette C., Paoloni-Giacobino A., Hans D., et al. A 3-year longitudinal study on body composition changes in the elderly: role of physical exercise. Clin Nutr 2006, 25:573-580.
10. Heinonen A., Kannus P., Sievanen H., Oja P., Pasanen M., Rinne M., et al. Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 1996, 348:1343-1347.
11. Steptoe A., Butler N. Sports participation and emotional wellbeing in adolescents. Lancet 1996, 347:1789-1792.
12. Lautenschlager N.T., Cox K.L., Flicker L., Foster J.K., van Bockxmeer F.M., Xiao J., et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. J Am Med Assoc 2008, 300:1027-1037.
13. Kim S.E., Ko I.G., Kim B.K., Shin M.S., Cho S., Kim C.J., et al. Treadmill exercise prevents aging-induced failure of memory through an increase in neurogenesis and suppression of apoptosis in rat hippocampus. Exp Gerontol 2010, 45:357-365.
14. Tipton K.D., Ferrando A.A., Phillips S.M., Doyle D., Wolfe R.R. Postexercise net protein synthesis in human muscle from orally administered amino acids. Am J Physiol 1999, 276:E628-E634.
15. Phillips S.M., Tipton K.D., Aarsland A., Wolf S.E., Wolfe R.R. Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am J Physiol 1997, 273:E99-E107.
16. Moore D.R., Phillips S.M., Babraj J.A., Smith K., Rennie M.J. Myofibrillar and collagen protein synthesis in human skeletal muscle in young men after maximal shortening and lengthening contractions. Am J Physiol Endocrinol Metab 2005, 288:E1153-E1159.
17. Donges C.E., Burd N.A., Duffield R., Smith G.C., West D.W., Short M.J., et al. Concurrent resistance and aerobic exercise stimulates both myofibrillar and mitochondrial protein synthesis in sedentary middle-aged men. J Appl Physiol (1985) 2012, 112:1992-2001.
18. Egan B., Zierath J.R. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 2013, 17:162-184.
19. Baar K., Esser K. Phosphorylation of p70(S6k) correlates with increased skeletal muscle mass following resistance exercise. Am J Physiol 1999, 276:C120-C127.
20. Kumar V., Selby A., Rankin D., Patel R., Atherton P., Hildebrandt W., et al. Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J Physiol 2009, 587:211-217.
21. Terzis G., Georgiadis G., Stratakos G., Vogiatzis I., Kavouras S., Manta P., et al. Resistance exercise-induced increase in muscle mass correlates with p70S6 kinase phosphorylation in human subjects. Eur J Appl Physiol 2008, 102:145-152.
22. Drummond M.J., Fry C.S., Glynn E.L., Dreyer H.C., Dhanani S., Timmerman K.L., et al. Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis. J Physiol 2009, 587:1535-1546.
23. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001, 3:1014-1019.
24. Ogasawara R., Kobayashi K., Tsutaki A., Lee K., Abe T., Fujita S., et al. mTOR signaling response to resistance exercise is altered by chronic resistance training and detraining in skeletal muscle. J Appl Physiol (1985) 2013, 114:934-940.
25. Goodman C.A., Frey J.W., Mabrey D.M., Jacobs B.L., Lincoln H.C., You J.S., et al. The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol 2011, 589:5485-5501.
26. Kimball S.R. Integration of signals generated by nutrients, hormones, and exercise in skeletal muscle. Am J Clin Nutr 2014, 99:237S-242S.
27. Hornberger T.A., Stuppard R., Conley K.E., Fedele M.J., Fiorotto M.L., Chin E.R., et al. Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism. Biochem J 2004, 380:795-804.
28. Spangenburg E.E., Le Roith D., Ward C.W., Bodine S.C. A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J Physiol 2008, 586:283-291.
29. Hamilton D.L., Philp A., MacKenzie M.G., Baar K. A limited role for PI(3,4,5)P3 regulation in controlling skeletal muscle mass in response to resistance exercise. PLoS ONE 2010, 5:e11624.
30. West D.W., Kujbida G.W., Moore D.R., Atherton P., Burd N.A., Padzik J.P., et al. Resistance exercise-induced increases in putative anabolic hormones do not enhance muscle protein synthesis or intracellular signalling in young men. J Physiol 2009, 587:5239-5247.
31. West D.W., Burd N.A., Tang J.E., Moore D.R., Staples A.W., Holwerda A.M., et al. Elevations in ostensibly anabolic hormones with resistance exercise enhance neither training-induced muscle hypertrophy nor strength of the elbow flexors. J Appl Physiol 2010, 108:60-67.
32. Jacobs B.L., You J.S., Frey J.W., Goodman C.A., Gundermann D.M., Hornberger T.A. Eccentric contractions increase the phosphorylation of tuberous sclerosis complex-2 (TSC2) and alter the targeting of TSC2 and the mechanistic target of rapamycin to the lysosome. J Physiol 2013, 591:4611-4620.
33. Tee A.R., Manning B.D., Roux P.P., Cantley L.C., Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003, 13:1259-1268.
34. Fluck M., Carson J.A., Gordon S.E., Ziemiecki A., Booth F.W. Focal adhesion proteins FAK and paxillin increase in hypertrophied skeletal muscle. Am J Physiol 1999, 277:C152-C162.
35. Gan B., Yoo Y., Guan J.L. Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth. J Biol Chem 2006, 281:37321-37329.
36. Wang J.G., Miyazu M., Matsushita E., Sokabe M., Naruse K. Uniaxial cyclic stretch induces focal adhesion kinase (FAK) tyrosine phosphorylation followed by mitogen-activated protein kinase (MAPK) activation. Biochem Biophys Res Commun 2001, 288:356-361.
37. Pankov R., Cukierman E., Clark K., Matsumoto K., Hahn C., Poulin B., et al. Specific beta1 integrin site selectively regulates Akt/protein kinase B signaling via local activation of protein phosphatase 2A. J Biol Chem 2003, 278:18671-18681.
38. Michele D.E., Campbell K.P. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem 2003, 278:15457-15460.
39. Moore C.J., Winder S.J. The inside and out of dystroglycan post-translational modification. Neuromusc Disorders 2012, 22:959-965.
40. Rybakova I.N., Patel J.R., Ervasti J.M. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol 2000, 150:1209-1214.
41. Spangenburg E.E., McBride T.A. Inhibition of stretch-activated channels during eccentric muscle contraction attenuates p70S6K activation. J Appl Physiol 2006, 100:129-135.
42. Fang Y., Vilella-Bach M., Bachmann R., Flanigan A., Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001, 294:1942-1945.
43. Veverka V., Crabbe T., Bird I., Lennie G., Muskett F.W., Taylor R.J., et al. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR. Oncogene 2008, 27:585-595.
44. Hornberger T.A., Chu W.K., Mak Y.W., Hsiung J.W., Huang S.A., Chien S. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci U S A 2006, 103:4741-4746.
45. You J.S., Lincoln H.C., Kim C.R., Frey J.W., Goodman C.A., Zhong X.P., et al. The role of diacylglycerol kinase zeta and phosphatidic acid in the mechanical activation of mammalian target of rapamycin (mTOR) signaling and skeletal muscle hypertrophy. J Biol Chem 2014, 289:1551-1563.
46. MacKenzie M.G., Hamilton D.L., Murray J.T., Taylor P.M., Baar K. mVps34 is activated following high-resistance contractions. J Physiol 2009, 587:253-260.
47. Crozier S.J., Kimball S.R., Emmert S.W., Anthony J.C., Jefferson L.S. Oral leucine administration stimulates protein synthesis in rat skeletal muscle. J Nutr 2005, 135:376-382.
48. Tang J.E., Moore D.R., Kujbida G.W., Tarnopolsky M.A., Phillips S.M. Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at rest and following resistance exercise in young men. J Appl Physiol (1985) 2009, 107:987-992.
49. Churchward-Venne T.A., Burd N.A., Mitchell C.J., West D.W., Philp A., Marcotte G.R., et al. Supplementation of a suboptimal protein dose with leucine or essential amino acids: effects on myofibrillar protein synthesis at rest and following resistance exercise in men. J Physiol 2012, 590:2751-2765.
50. Moberg M., Apro W., Ohlsson I., Ponten M., Villanueva A., Ekblom B., et al. Absence of leucine in an essential amino acid supplement reduces activation of mTORC1 signalling following resistance exercise in young females. Appl Physiol Nutr Metab 2014, 39:183-194.
51. Kim E., Goraksha-Hicks P., Li L., Neufeld T.P., Guan K.L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 2008, 10:935-945.
52. Sancak Y., Peterson T.R., Shaul Y.D., Lindquist R.A., Thoreen C.C., Bar-Peled L., et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320:1496-1501.
53. Bar-Peled L., Chantranupong L., Cherniack A.D., Chen W.W., Ottina K.A., Grabiner B.C., et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013, 340:1100-1106.
54. Bar-Peled L., Schweitzer L.D., Zoncu R., Sabatini D.M. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012, 150:1196-1208.
55. Han J.M., Jeong S.J., Park M.C., Kim G., Kwon N.H., Kim H.K., et al. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012, 149:410-424.
56. Tsun Z.Y., Bar-Peled L., Chantranupong L., Zoncu R., Wang T., Kim C., et al. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol Cell 2013, 52:495-505.
57. Sancak Y., Bar-Peled L., Zoncu R., Markhard A.L., Nada S., Sabatini D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
58. Drummond M.J., Fry C.S., Glynn E.L., Timmerman K.L., Dickinson J.M., Walker D.K., et al. Skeletal muscle amino acid transporter expression is increased in young and older adults following resistance exercise. J Appl Physiol (1985) 2011, 111:135-142.
59. Welle S., Nair K.S. Relationship of resting metabolic rate to body composition and protein turnover. Am J Physiol 1990, 258:E990-E998.
60. Cunningham J.T., Rodgers J.T., Arlow D.H., Vazquez F., Mootha V.K., Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007, 450:736-740.
61. Baar K., Wende A.R., Jones T.E., Marison M., Nolte L.A., Chen M., et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 2002, 16:1879-1886.
62. Holloszy J.O. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 1967, 242:2278-2282.
63. Carter H.N., Hood D.A. Contractile activity-induced mitochondrial biogenesis and mTORC1. Am J Physiol Cell Physiol 2012, 303:C540-C547.
64. Breen L., Philp A., Witard O.C., Jackman S.R., Selby A., Smith K., et al. The influence of carbohydrate-protein co-ingestion following endurance exercise on myofibrillar and mitochondrial protein synthesis. J Physiol 2011, 589:4011-4025.
65. Philp A., Schenk S., Breen L., Hamilton L., Scott F., Laverone E., et al. Differential regulation of myofibrillar and mitochondrial protein synthesis following acute endurance exercise (702.3). FASEB J 2014, 28.
66. Choo A.Y., Yoon S.O., Kim S.G., Roux P.P., Blenis J. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci U S A 2008, 105:17414-17419.
67. Morita M., Gravel S.P., Chenard V., Sikstrom K., Zheng L., Alain T., et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab 2013, 18:698-711.
68. Williamson D., Gallagher P., Harber M., Hollon C., Trappe S. Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle. J Physiol 2003, 547:977-987.
69. Chen Z.P., Stephens T.J., Murthy S., Canny B.J., Hargreaves M., Witters L.A., et al. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes 2003, 52:2205-2212.
70. Winder W.W., Hardie D.G. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 1996, 270:E299-E304.
71. Winder W.W., Holmes B.F., Rubink D.S., Jensen E.B., Chen M., Holloszy J.O. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 2000, 88:2219-2226.
72. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
73. Thomson D.M., Fick C.A., Gordon S.E. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions. J Appl Physiol 2008, 104:625-632.
74. Mounier R., Lantier L., Leclerc J., Sotiropoulos A., Pende M., Daegelen D., et al. Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy. FASEB J 2009, 23:2264-2273.
75. Lundberg T.R., Fernandez-Gonzalo R., Tesch P.A. Exercise-induced AMPK activation does not interfere with muscle hypertrophy in response to resistance training in men. J Appl Physiol (1985) 2014, 116:611-620.
76. Coffey V.G., Jemiolo B., Edge J., Garnham A.P., Trappe S.W., Hawley J.A. Effect of consecutive repeated sprint and resistance exercise bouts on acute adaptive responses in human skeletal muscle. Am J Physiol Regulat Integr Comp Physiol 2009, 297:R1441-R1451.
77. Apro W., Wang L., Ponten M., Blomstrand E., Sahlin K. Resistance exercise induced mTORC1 signaling is not impaired by subsequent endurance exercise in human skeletal muscle. Am J Physiol Endocrinol Metab 2013, 305:E22-E32.
78. Hickson R.C. Interference of strength development by simultaneously training for strength and endurance. Eur J Appl Physiol Occup Physiol 1980, 45:255-263.
79. Kraemer W.J., Patton J.F., Gordon S.E., Harman E.A., Deschenes M.R., Reynolds K., et al. Compatibility of high-intensity strength and endurance training on hormonal and skeletal muscle adaptations. J Appl Physiol (1985) 1995, 78:976-989.
80. Wilson J.M., Marin P.J., Rhea M.R., Wilson S.M., Loenneke J.P., Anderson J.C. Concurrent training: a meta-analysis examining interference of aerobic and resistance exercises. J Strength Cond Res/Natl Strength Cond Assoc 2012, 26:2293-2307.
81. Ehsani A.A., Hagberg J.M., Hickson R.C. Rapid changes in left ventricular dimensions and mass in response to physical conditioning and deconditioning. Am J Cardiol 1978, 42:52-56.
82. Pluim B.M., Zwinderman A.H., van der Laarse A., van der Wall E.E. The athlete's heart. A meta-analysis of cardiac structure and function. Circulation 2000, 101:336-344.
83. 2+ ATPase function is increased by aerobic interval training. Eur J Cardiovasc Prev Rehabil 2008, 15:145-148.
84. Fagard R.H. Athlete's heart: a meta-analysis of the echocardiographic experience. Int J Sports Med 1996, 17(Suppl. 3):S140-S144.
85. McMullen J.R., Shioi T., Zhang L., Tarnavski O., Sherwood M.C., Kang P.M., et al. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci U S A 2003, 100:12355-12360.
86. DeBosch B., Treskov I., Lupu T.S., Weinheimer C., Kovacs A., Courtois M., et al. Akt1 is required for physiological cardiac growth. Circulation 2006, 113:2097-2104.
87. Bloch R.J., Capetanaki Y., O'Neill A., Reed P., Williams M.W., Resneck W.G., et al. Costameres: repeating structures at the sarcolemma of skeletal muscle. Clin Orthop 2002, S203-S210.
88. Ross R.S., Borg T.K. Integrins and the myocardium. Circ Res 2001, 88:1112-1119.
89. Fukuda K., Gupta S., Chen K., Wu C., Qin J. The pseudoactive site of ILK is essential for its binding to alpha-Parvin and localization to focal adhesions. Mol Cell 2009, 36:819-830.
90. Ghatak S., Morgner J., Wickstrom S.A. ILK: a pseudokinase with a unique function in the integrin-actin linkage. Biochem Soc Trans 2013, 41:995-1001.
91. Brancaccio M., Fratta L., Notte A., Hirsch E., Poulet R., Guazzone S., et al. Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat Med 2003, 9:68-75.
92. McDonald P.C., Oloumi A., Mills J., Dobreva I., Maidan M., Gray V., et al. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 2008, 68:1618-1624.
93. De Acetis M., Notte A., Accornero F., Selvetella G., Brancaccio M., Vecchione C., et al. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload. Circ Res 2005, 96:1087-1094.
94. Keller R.S., Shai S.Y., Babbitt C.J., Pham C.G., Solaro R.J., Valencik M.L., et al. Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. Am J Pathol 2001, 158:1079-1090.
95. Valencik M.L., Keller R.S., Loftus J.C., McDonald J.A. A lethal perinatal cardiac phenotype resulting from altered integrin function in cardiomyocytes. J Card Fail 2002, 8:262-272.
96. Bendig G., Grimmler M., Huttner I.G., Wessels G., Dahme T., Just S., et al. Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart. Genes Dev 2006, 20:2361-2372.
97. Shen T.L., Guan J.L. Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett 2001, 499:176-181.
98. Del Re D.P., Miyamoto S., Brown J.H. Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection. J Biol Chem 2008, 283:35622-35629.
99. Pham C.G., Harpf A.E., Keller R.S., Vu H.T., Shai S.Y., Loftus J.C., et al. Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway. Am J Physiol Heart Circ Physiol 2000, 279:H2916-H2926.
100. Bueno O.F., De Windt L.J., Tymitz K.M., Witt S.A., Kimball T.R., Klevitsky R., et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000, 19:6341-6350.
101. McMullen J.R., Shioi T., Huang W.Y., Zhang L., Tarnavski O., Bisping E., et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110alpha) pathway. J Biol Chem 2004, 279:4782-4793.
102. Mejri S., Bchir F., Ben Rayana M.C., Ben Hamida J., Ben Slama C. Effect of training on GH and IGF-1 responses to a submaximal exercise in football players. Eur J Appl Physiol 2005, 95:496-503.
103. Coleman M.E., DeMayo F., Yin K.C., Lee H.M., Geske R., Montgomery C., et al. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 1995, 270:12109-12116.
104. Astrand P.O., Cuddy T.E., Saltin B., Stenberg J. Cardiac output during submaximal and maximal work. J Appl Physiol (1985) 1964, 19:268-274.
105. Kemi O.J., Ceci M., Wisloff U., Grimaldi S., Gallo P., Smith G.L., et al. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol 2008, 214:316-321.
106. Brown J., Cooper-Kuhn C.M., Kempermann G., Van Praag H., Winkler J., Gage F.H., et al. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci 2003, 17:2042-2046.
107. van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 1999, 2:266-270.
108. Erickson K.I., Voss M.W., Prakash R.S., Basak C., Szabo A., Chaddock L., et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 2011, 108:3017-3022.
109. Chaddock L., Erickson K.I., Prakash R.S., Kim J.S., Voss M.W., Vanpatter M., et al. A neuroimaging investigation of the association between aerobic fitness, hippocampal volume, and memory performance in preadolescent children. Brain Res 2010, 1358:172-183.
110. Erickson K.I., Prakash R.S., Voss M.W., Chaddock L., Hu L., Morris K.S., et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 2009, 19:1030-1039.
111. Aberg M.A., Pedersen N.L., Toren K., Svartengren M., Backstrand B., Johnsson T., et al. Cardiovascular fitness is associated with cognition in young adulthood. Proc Natl Acad Sci U S A 2009, 106:20906-20911.
112. Neeper S.A., Gomez-Pinilla F., Choi J., Cotman C.W. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 1996, 726:49-56.
113. Suijo K., Inoue S., Ohya Y., Odagiri Y., Takamiya T., Ishibashi H., et al. Resistance exercise enhances cognitive function in mouse. Int J Sports Med 2013, 34:368-375.
114. Griffin E.W., Mullally S., Foley C., Warmington S.A., O'Mara S.M., Kelly A.M. Aerobic exercise improves hippocampal function and increases BDNF in the serum of young adult males. Physiol Behav 2011, 104:934-941.
115. Marosi K., Mattson M.P. BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol Metab 2014, 25:89-98.
116. Fang Z.H., Lee C.H., Seo M.K., Cho H., Lee J.G., Lee B.J., et al. Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats. Neurosci Res 2013, 76:187-194.
117. Chen M.J., Russo-Neustadt A.A. Exercise activates the phosphatidylinositol 3-kinase pathway. Brain Res Mol Brain Res 2005, 135:181-193.
118. Takei N., Inamura N., Kawamura M., Namba H., Hara K., Yonezawa K., et al. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J Neurosci 2004, 24:9760-9769.
119. Stoica L., Zhu P.J., Huang W., Zhou H., Kozma S.C., Costa-Mattioli M. Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc Natl Acad Sci U S A 2011, 108:3791-3796.
120. Seo T.B., Cho H.S., Shin M.S., Kim C.J., Ji E.S., Baek S.S. Treadmill exercise improves behavioral outcomes and spatial learning memory through up-regulation of reelin signaling pathway in autistic rats. J Exerc Rehabil 2013, 9:220-229.
121. Jossin Y., Goffinet A.M. Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth. Mol Cell Biol 2007, 27:7113-7124.
122. Hesari F., Sale E. Reelin and regular exercise in the brain cortex of healthy adult rats. J Anim Sci Adv 2013, (3):569-574.
123. Ruderman N.B., Park H., Kaushik V.K., Dean D., Constant S., Prentki M., et al. AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol Scand 2003, 178:435-442.
124. Laplante M., Sabatini D.M. An emerging role of mTOR in lipid biosynthesis. Curr Biol 2009, 19:R1046-R1052.
125. Reiter A.K., Bolster D.R., Crozier S.J., Kimball S.R., Jefferson L.S. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside. Am J Physiol Endocrinol Metab 2005, 288:E980-E988.
126. Miller R.A., Harrison D.E., Astle C.M., Baur J.A., Boyd A.R., de Cabo R., et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol Ser A: Biol Sci Med Sci 2011, 66:191-201.